Nuvation Bio
Utility Patents

Last updated:

List of all Nuvation Bio patents 10 in total

Status Patent
Grant
Utility: Heterocyclic compounds as adenosine antagonists External link
Filling date: 6 Sep 2025 Issue date: 19 Apr 2022
Grant
Utility: Heterocyclic compounds and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Diarylhydantoin compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: 1,8-naphthyridinone compounds and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors External link
Filling date: 6 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Heterocyclic compounds as kinase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 16 Nov 2021
Grant
Utility: Pyrrole and pyrazole compounds and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Heterocyclic compounds as adenosine antagonists External link
Filling date: 6 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Heterocyclic compounds and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 20 Oct 2020
Grant
Utility: 1,8-naphthyridinone compounds and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 6 Oct 2020

Showing 1 to 10 of 10 patents.